Following approval of a price increase for coronary stents by the National Pharmaceutical Pricing Authority, treatment expenses for heart patients are expected to increase. When the MRP is adjusted for inflation, the cost of the life-saving gadgets will increase by about Rs 700 in certain situations. Stents, which are frequently an essential component of treatment for many patients, are placed into constricted or obstructed coronary arteries to maintain their opening and enhance heart blood flow.
The National Pharmaceutical Pricing Authority on Thursday issued a circular instructing all coronary stent makers and importers to examine and amend the cost (if lower) by 1.74028% of the wholesale price index for 2024, according to a Business Standard article. The memo also stated that manufacturers that failed to adhere to the ceiling price would be required to deposit the overpriced amount plus interest, according to the publication.
